RA
INSIDER · LGND · LIGAND PHARMACEUTICALS INC · CLO & SECRETARY
Reardon Andrew
Every open-market transaction filed under this name, Sep 3 to Oct 2.
Filings
11
0 buys · 11 sells
Bought
—
open market, at cost
Sold
$3M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 2 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 17 | $307.74 | $5K | — |
| Oct 2 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 235 | $307.19 | $72K | — |
| Oct 2 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 404 | $306.18 | $124K | — |
| Oct 2 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 1,535 | $304.52 | $467K | — |
| Oct 2 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 1,976 | $303.54 | $600K | — |
| Oct 2 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 833 | $302.51 | $252K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 400 | $288.98 | $116K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 385 | $287.53 | $111K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 2,115 | $286.36 | $606K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 1,800 | $285.17 | $513K | — |
| Sep 3 | LGND | LIGAND PHARMACEUTICALS INC | CLO & Secretary | Sell | 300 | $283.99 | $85K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.